• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多药外排泵与癌症干细胞:多药耐药机制与治疗开发的新视角。

Multidrug efflux pumps and cancer stem cells: insights into multidrug resistance and therapeutic development.

机构信息

Laboratory of Experimental Immunology, Human Genetics Section, Cancer and Inflammation Program, National Cancer Institute at Frederick, Frederick, Maryland, USA.

出版信息

Clin Pharmacol Ther. 2011 Apr;89(4):491-502. doi: 10.1038/clpt.2011.14. Epub 2011 Mar 2.

DOI:10.1038/clpt.2011.14
PMID:21368752
Abstract

Stem cells possess the dual properties of self-renewal and pluripotency. Self-renewal affords these populations the luxury of self-propagation, whereas pluripotency allows them to produce the multitude of cell types found in the body. Protection of the stem cell population from damage or death is critical because these cells need to remain intact throughout the life of an organism. The principal mechanism of protection is through expression of multifunctional efflux transporters--the adenosine triphosphate-binding cassette (ABC) transporters that are the "guardians" of the stem cell population. Ironically, it has been shown that these ABC efflux pumps also afford protection to cancer stem cells (CSCs), shielding them from the adverse effects of chemotherapeutic insult. It is therefore imperative to gain a better understanding of the mechanisms involved in the resistance of stem cells to chemotherapy, which could lead to the discovery of new therapeutic targets and improvement of current anticancer strategies.

摘要

干细胞具有自我更新和多能性的双重特性。自我更新使这些细胞群体能够自我繁殖,而多能性则使它们能够产生体内存在的多种细胞类型。保护干细胞群体免受损伤或死亡至关重要,因为这些细胞需要在生物体的整个生命周期内保持完整。主要的保护机制是通过表达多功能外排转运体——三磷酸腺苷结合盒(ABC)转运体,它们是干细胞群体的“守护者”。具有讽刺意味的是,已经表明这些 ABC 外排泵也为癌症干细胞 (CSC) 提供了保护,使其免受化疗损伤的不利影响。因此,迫切需要更好地了解干细胞对化疗的耐药机制,这可能导致发现新的治疗靶点和改进现有的抗癌策略。

相似文献

1
Multidrug efflux pumps and cancer stem cells: insights into multidrug resistance and therapeutic development.多药外排泵与癌症干细胞:多药耐药机制与治疗开发的新视角。
Clin Pharmacol Ther. 2011 Apr;89(4):491-502. doi: 10.1038/clpt.2011.14. Epub 2011 Mar 2.
2
Tackling multidrug resistance mediated by efflux transporters in tumor-initiating cells.应对肿瘤起始细胞中由外排转运蛋白介导的多药耐药性。
Expert Opin Drug Metab Toxicol. 2016 Jun;12(6):633-44. doi: 10.1080/17425255.2016.1179280. Epub 2016 May 4.
3
Overcoming Multidrug Resistance in Cancer Stem Cells.克服癌症干细胞中的多药耐药性。
Biomed Res Int. 2015;2015:635745. doi: 10.1155/2015/635745. Epub 2015 Nov 16.
4
ABC transporters, drug resistance, and cancer stem cells.ABC转运蛋白、耐药性与癌症干细胞
J Mammary Gland Biol Neoplasia. 2009 Mar;14(1):3-9. doi: 10.1007/s10911-009-9109-9. Epub 2009 Feb 18.
5
Insights into new mechanisms and models of cancer stem cell multidrug resistance.癌症干细胞多药耐药性新机制和新模型的研究进展。
Semin Cancer Biol. 2020 Feb;60:166-180. doi: 10.1016/j.semcancer.2019.07.022. Epub 2019 Jul 29.
6
The ABCs of cancer stem cell drug resistance.癌症干细胞耐药性的基本要点
IDrugs. 2010 Sep;13(9):632-5.
7
Targeting multidrug resistance in cancer.针对癌症中的多药耐药性
Nat Rev Drug Discov. 2006 Mar;5(3):219-34. doi: 10.1038/nrd1984.
8
ABC Transporters in the Development of Multidrug Resistance in Cancer Therapy.ABC转运蛋白在癌症治疗中多药耐药性的发展过程中所起的作用
Curr Pharm Des. 2016;22(30):4705-4716. doi: 10.2174/1381612822666160302103646.
9
The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade.ABC 转运体介导的癌症多药耐药性的调节:过去十年的综述。
Drug Resist Updat. 2015 Jan;18:1-17. doi: 10.1016/j.drup.2014.11.002. Epub 2014 Dec 10.
10
ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance.ABC 转运蛋白在肿瘤干细胞中的作用:超越化疗耐药性。
Int J Mol Sci. 2017 Nov 8;18(11):2362. doi: 10.3390/ijms18112362.

引用本文的文献

1
The Underlying Mechanisms and Emerging Strategies to Overcome Resistance in Breast Cancer.克服乳腺癌耐药性的潜在机制与新兴策略
Cancers (Basel). 2025 Sep 8;17(17):2938. doi: 10.3390/cancers17172938.
2
Multidrug Resistance: Are We Still Afraid of the Big Bad Wolf.多重耐药性:我们还怕那只大坏狼吗?
Pharmaceuticals (Basel). 2025 Jun 14;18(6):895. doi: 10.3390/ph18060895.
3
The Metabolic Landscape of Cancer Stem Cells: Insights and Implications for Therapy.癌症干细胞的代谢格局:对治疗的见解与启示
Cells. 2025 May 15;14(10):717. doi: 10.3390/cells14100717.
4
The dual role of autophagy in cancer stem cells: implications for tumor progression and therapy resistance.自噬在癌症干细胞中的双重作用:对肿瘤进展和治疗抗性的影响。
J Transl Med. 2025 May 25;23(1):583. doi: 10.1186/s12967-025-06595-z.
5
Therapeutic Targeting in Ovarian Cancer: Nano-Enhanced CRISPR/Cas9 Gene Editing and Drug Combination Therapy.卵巢癌的治疗靶点:纳米增强型CRISPR/Cas9基因编辑与联合药物治疗
Int J Nanomedicine. 2025 Mar 30;20:3907-3931. doi: 10.2147/IJN.S507688. eCollection 2025.
6
Deciphering the Role of Cancer Stem Cells: Drivers of Tumor Evolution, Therapeutic Resistance, and Precision Medicine Strategies.解读癌症干细胞的作用:肿瘤进化、治疗抗性及精准医学策略的驱动因素
Cancers (Basel). 2025 Jan 24;17(3):382. doi: 10.3390/cancers17030382.
7
Expression of ABCB1, ABCC1, and LRP in Mesenchymal Stem Cells from Human Amniotic Fluid and Bone Marrow in Culture-Effects of In Vitro Osteogenic and Adipogenic Differentiation.ABCB1、ABCC1和LRP在人羊水间充质干细胞和培养的骨髓间充质干细胞中的表达——体外成骨和成脂分化的影响
Int J Mol Sci. 2025 Jan 9;26(2):510. doi: 10.3390/ijms26020510.
8
Research advancements in nanoparticles and cell-based drug delivery systems for the targeted killing of cancer cells.用于靶向杀死癌细胞的纳米颗粒和基于细胞的药物递送系统的研究进展。
Oncol Res. 2024 Dec 20;33(1):27-44. doi: 10.32604/or.2024.056955. eCollection 2025.
9
Intercellular transfer of multidrug resistance mediated by extracellular vesicles.细胞外囊泡介导的多药耐药性的细胞间转移。
Cancer Drug Resist. 2024 Sep 21;7:36. doi: 10.20517/cdr.2024.84. eCollection 2024.
10
3D Tumor-Engineered Model Replicating the Osteosarcoma Stem Cell Niche and Tumor Complexity.复制骨肉瘤干细胞微环境和肿瘤复杂性的3D肿瘤工程模型
ACS Appl Mater Interfaces. 2024 Oct 1;16(41):55011-26. doi: 10.1021/acsami.4c02567.